Publication | Closed Access

Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability

Surgical OncologyGastrointestinal OncologyMedicineSalvage TreatmentColorectal CancerMetastatic Colorectal CancerSurgeryMetronomic ChemotherapyCancer TreatmentOncologyRadiation Oncology